Moxifloxacin 0.5% Ophthalmic Solution: In Bacterial Conjunctivitis

Author： Keating Gillian M.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.1, 2011-01, pp. : 89-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Azithromycin 1.5% Ophthalmic Solution: In Purulent Bacterial or Trachomatous Conjunctivitis

By Garnock-Jones Karly P.  

Drugs, Vol. 72, Iss. 3, 2012-02 ,pp. : 361-373

Adis International

Access to resources Recommend Favorite

The Role of Topical Moxifloxacin, a New Antibacterial in Europe, in the Treatment of Bacterial Conjunctivitis

By Benitez-del-Castillo Jose  

Clinical Drug Investigation, Vol. 31, Iss. 8, 2011-08 ,pp. : 543-557

Adis International

Access to resources Recommend Favorite

Besifloxacin Ophthalmic Suspension 0.6% Administered Twice Daily for 3 Days in the Treatment of Bacterial Conjunctivitis in Adults and Children

By DeLeon Jesse  

Clinical Drug Investigation, Vol. 32, Iss. 5, 2012-05 ,pp. : 303-317

Adis International

Access to resources Recommend Favorite

Post-Marketing Surveillance of Levofloxacin 0.5% Ophthalmic Solution for External Ocular Infections

By Kanda Yoshiko  

Drugs in R&D, Vol. 12, Iss. 4, 2012-12 ,pp. : 177-185

Adis International

Access to resources Recommend Favorite

Topical Brimonidine 0.2%/Timolol 0.5% Ophthalmic Solution: In Glaucoma and Ocular Hypertension

By Frampton James E.  

Drugs & Aging, Vol. 23, Iss. 9, 2006-01 ,pp. : 753-761

Adis International

Access to resources Recommend Favorite